Paper42650751
Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study.
Brouer IC and 4 others. Biomolecules, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study. Papers, record 42650751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42650751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pregnancy Outcome | Major topic |
| Pregnancy Complications | Major topic |
| Antirheumatic Agents | Major topic |
| Inflammation | Major topic |
| Humans | |
| Female | |
| Pregnancy | |
| Retrospective Studies | |
| Adult | |
| Azathioprine | |
| Interleukin-23 | |
| Methotrexate | |
| Tumor Necrosis Factor Inhibitors |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37193038 | A global federated real-world data and analytics platform for research. | JAMIA Open | 2023 | https://conductscience.org/library/papers/37193038 | PubMed |
| 2 | 32118278 | Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/32118278 | PubMed |
| 3 | 40372753 | Use of Biologics During Pregnancy Among Patients With Autoimmune Conditions. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40372753 | PubMed |
| 4 | 31373768 | Mediation of Adverse Pregnancy Outcomes in Autoimmune Conditions by Pregnancy Complications: A Mediation Analysis of Autoimmune Conditions and Adverse Pregnancy Outcomes. | Arthritis Care Res (Hoboken) | 2020 | https://conductscience.org/library/papers/31373768 | PubMed |
| 5 | 38899437 | Changes in the prevalence of maternal chronic conditions during pregnancy: A nationwide age-period-cohort analysis. | BJOG | 2025 | https://conductscience.org/library/papers/38899437 | PubMed |
| 6 | 26559393 | Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis. | J Eur Acad Dermatol Venereol | 2016 | https://conductscience.org/library/papers/26559393 | PubMed |
| 7 | 33227283 | Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. | Gastroenterology | 2021 | https://conductscience.org/library/papers/33227283 | PubMed |
| 8 | 37033665 | IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37033665 | PubMed |
| 9 | 39626647 | Biologics Use for Psoriasis during Pregnancy and Its Related Adverse Outcomes in Pregnant Women and Newborns: Findings from WHO Pharmacovigilance Study. | Int Arch Allergy Immunol | 2025 | https://conductscience.org/library/papers/39626647 | PubMed |
| 10 | 23134993 | Treatment of severe psoriasis with ustekinumab during pregnancy. | J Drugs Dermatol | 2012 | https://conductscience.org/library/papers/23134993 | PubMed |
| 11 | 12535207 | IL-12 completely blocks ultraviolet-induced secretion of tumor necrosis factor alpha from cultured skin fibroblasts and keratinocytes. | J Invest Dermatol | 2003 | https://conductscience.org/library/papers/12535207 | PubMed |
| 12 | 39834709 | Global trends in immune mediated inflammatory diseases: Psoriasis, atopic dermatitis, multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis. | JAAD Int | 2025 | https://conductscience.org/library/papers/39834709 | PubMed |
| 13 | 25378092 | Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis. | Hum Exp Toxicol | 2015 | https://conductscience.org/library/papers/25378092 | PubMed |
| 14 | 34748293 | Ustekinumab Safety in Pregnancy: A Comprehensive Review. | Arthritis Care Res (Hoboken) | 2023 | https://conductscience.org/library/papers/34748293 | PubMed |
| 15 | 34874264 | Pregnancy and Autoimmune Disease. | Dtsch Arztebl Int | 2022 | https://conductscience.org/library/papers/34874264 | PubMed |
| 16 | 23752881 | Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. | Am J Gastroenterol | 2013 | https://conductscience.org/library/papers/23752881 | PubMed |
| 17 | 34581874 | [Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding]. | Z Rheumatol | 2021 | https://conductscience.org/library/papers/34581874 | PubMed |
| 18 | 37731935 | Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/37731935 | PubMed |
| 19 | 40129946 | A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40129946 | PubMed |
| 20 | 35014759 | Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis. | BJOG | 2022 | https://conductscience.org/library/papers/35014759 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42650751
GET https://conductscience.org/api/papers/v1/42650751/references?page=2